Generic medicines, affordable solutions.

Scientific|Regulatory

Intellectual Property

Pharma Review

Current Issues

EGA Position Papers

EC SECTOR INQUIRY

European Commission Inquiry into the Pharmaceutical Sector

EC INQUIRY REVEALS INDUSTRY BARRIERS TO AFFORDABLE GENERIC MEDICINES

DG Competition reports tactics by originator pharmaceutical companies has cost society €3 billion.
 

REPORT: “Originator companies have designed and implemented strategies (a “tool-box” of instruments) aimed at ensuring continued revenue streams for their medicines...” More ...

EGA Press Release Commission Press Release Preliminary Report from DG Competition DG Competition/Inquiry Website EGA RESPONSE to the Public Consultation  EGA Presentation on the Inquiry Findings EGA REPORT: Patent-related Barriers to Market Entry
for Generic Medicines in the EU
"IP Policy Developments in the EU and Implications for the Generic Medicines Industry" A presentation delivered at the 12th Annual IGPA Conference, Montreal (Canada) 30 September - 2 October 2009 - Lidia Mallo, Government Affairs, EGA